Browsing by Author Meza, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2003A pilot study of a novel anti-inflammatory and anti-fibrotic agent, pirfenidone, in patients with liver cirrhosis.Armendariz-Borunda, J; Islas-Carbajal, MC; Meza, E; Rincon, AR; Alvarez, A; Goodman, ZD; Sandoval, A; Covarrubias, A; Arechiga, G; Garcia, L; Univ Guadalajara, OPD Hosp Civil de Guadalajara, Guadalajara 44430, Jalisco, Mexico; Armed Forces Inst Pathol, Washington, DC 20306 USA; Hosp Civil Guadalajara Juan I Menchaca, Guadalajara, Jalisco, Mexico
2003A pilot study of a novel anti-inflammatory and anti-fibrotic agent, pirfenidone, in patients with liver cirrhosis.Armendariz-Borunda, J; Islas-Carbajal, MC; Meza, E; Rincon, AR; Alvarez, A; Goodman, ZD; Sandoval, A; Covarrubias, A; Arechiga, G; García, L; Univ Guadalajara, OPD Hosp Civil de Guadalajara, Guadalajara 44430, Jalisco, Mexico; Armed Forces Inst Pathol, Washington, DC 20306 USA; Hosp Civil Guadalajara Juan I Menchaca, Guadalajara, Jalisco, Mexico
2004Relationship of fibrogenic polymorphisms (TGFB, PAI-1, AT) and pirfenidone treatment response in Mexican cirrhotic patients.Armendariz-Borunda, K; Bueno-Topete, M; Munoz-Valle, JF; Oregon-Romero, E; Rincon-Sanchez, AR; Meza, E; Islas-Carvajal, MC; Sandoval, AS; Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico
2004Relationship of fibrogenic polymorphisms (TGFB, PAI-1, AT) and pirfenidone treatment response in Mexican cirrhotic patients.Armendariz-Borunda, K; Bueno-Topete, M; Munoz-Valle, JF; Oregon-Romero, E; Rincon-Sanchez, AR; Meza, E; Islas-Carvajal, MC; Sandoval, AS; Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico